Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine in Acute Phosphide Poisoning
NCT03953248Phase 1Completed
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of levocarnitine in Phosphide poisoning (2 arms). Primary endpoint: Mortality at 2 years. Started Jan 2016; status: completed.
02
Drugs
levocarnitine
03
Conditions
Phosphide poisoning
Beyond the preview
Go deeper on NCT03953248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03953248.